Jazz Pharmaceuticals, Inc.
Registered Principal Details
Cessation Date
4/24/2024 2:17:56 PM
Business Or Interest:
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Bruce Cozadd
4/24/2024 2:17:56 PM
Business Or Interest:
Pharmaceutical manufacturing and healthcare
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Bruce Cozadd
Contact
JUS
Jennie U Skelton
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
greenwichbio@politicomlaw.com
http://www.jazzpharma.com
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
greenwichbio@politicomlaw.com
http://www.jazzpharma.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Annie Early | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On 4/24/2024 |
| Jeremey J Shepherd | Exclusive Duties No | Authorized On 12/23/2022 | Withdrawn On 4/24/2024 |
| Daniela Sharfstein | Exclusive Duties No | Authorized On 12/28/2022 | Withdrawn On 2/15/2023 |
| Kurt Stembridge | Exclusive Duties No | Authorized On 4/24/2023 | Withdrawn On 2/21/2024 |
Lobbying Interests
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
All matters or issues relating to pharmaceuticals
All matters or issues relating to pharmaceuticals
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
All matters relating to medical marijuana
All matters relating to medical marijuana
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Any legislation or rule that impacts access to Epidolex or its successor name, or cannabinol in a drug product approved by the United States Food and Drug Administration
Development, drafting or introduction of a proposal relating to
Any legislation or rule that impacts access to Epidolex or its successor name, or cannabinol in a drug product approved by the United States Food and Drug Administration
Any legislation or rule that impacts access to Epidolex or its successor name, or cannabinol in a drug product approved by the United States Food and Drug Administration
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
all matters affecting the regulation and reimbursement of CBD products and the effects on consumers
all matters affecting the regulation and reimbursement of CBD products and the effects on consumers
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/15/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $27,000.00 |
2023 July - December $27,000.00 |
2024 January - June $0.00 |
Total $54,000.00 |
| Total Hours Communicating | 2023 January - June 3.25 |
2023 July - December 4.75 |
2024 January - June 0.00 |
Total 8.00 |
| Total Hours Other | 2023 January - June 6.50 |
2023 July - December 5.75 |
2024 January - June 0.00 |
Total 12.25 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 20% |
2023 July - December 40% |
2024 January - June |
2024 July - December |
Total 30% |
Any legislation or rule that impacts access to Epidolex or its successor name, or cannabinol in a drug product approved by the United States Food and Drug Administration
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 20% |
2024 January - June |
2024 July - December |
Total 10% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication